Tag: Markus Manns
Was der neue CEO jetzt liefern muss
Bill Anderson Der neue Bayer-Chef steht unter Druck, 2024 wieder deutlich bessere Zahlen zu liefern. (Foto: Reuters) Düsseldorf Das erste Geschäftsjahr des neuen Bayer-Chefs Bill Anderson wird für den Pharmakonzern ein…
Curevac will Entschädigung von Biontech
Düsseldorf Der milliardenschwere Patentstreit um den Corona-Impfstoff des Mainzer Unternehmens Biontech geht in die entscheidende Phase. Ende September will das Düsseldorfer Landgericht ein Urteil über vier der fünf Anklagepunkte verkünden,…
Seven years of Bayer CEO in seven graphics
Bayer CEO Werner Baumann On Tuesday he presented his last year’s balance sheet as CEO of Bayer. (Photo: Sepp Spiegl) Dusseldorf Bayer boss Werner Baumann refrained from big parting words…
Investors are demanding a new CEO from outside
Werner Bauman The Bayer boss will vacate his post by April 2024 at the latest. (Photo: imago images/sepp spiegl) Dusseldorf, Frankfurt The entry of several activist investors into Bayer continues…
Investors are demanding a new CEO from outside
Werner Bauman The Bayer boss will vacate his post by April 2024 at the latest. (Photo: imago images/sepp spiegl) Dusseldorf, Frankfurt The entry of several activist investors into Bayer continues…
Three reasons why Bayer is currently losing value on the stock exchange
Dusseldorf Thanks to a strong agricultural business, the pharmaceutical and agrochemical group Bayer exceeded expectations in the third quarter and is heading for record results for 2022. “We are well…
Hope for a quick end to the glyphosate trial is fading
Dusseldorf In the legal dispute over the alleged health risks of the weed killer glyphosate, Bayer has suffered a serious setback in the USA. In a statement, the US Department…